A new licensing agreement between three parties will allow CRISPR-Cas9 and similar gene editing tools to be used to produce camelina varieties for biofuel advancement.
Your Agri-Pulse trial will expire in less than two weeks.
To continue receiving full access to Agri-Pulse reporting, newsletters, podcasts and subscriber-exclusive content, visit our subscription page to choose a monthly or annual membership plan.
Questions about pricing or eligibility for discounted rates? Email paige@agri-pulse.com.